Biotech Archives - Page 67 of 71 - Life Sciences Times

Boston Scientific to Acquire Nalu Medical in $600 Million Deal to Expand Chronic Pain Solutions

October 17, 2025

Parabilis Medicines Unveils Groundbreaking Clinical Data Showing First-Ever Drugging of Key Cancer Driver with FOG-001

October 17, 2025

Zelis Study Finds Employers and Consumers See AI, Price Transparency, and Digital Tools as Keys to Better Healthcare

October 16, 2025

THIS WEEK'S STORIES

CMS Grants HCPCS Code and NTAP Classification for Pleural Dynamics’ ACES Automatic Continuous Effusion Shunt

October 14, 2025

OutcomesAI Raises $10 Million Seed Round Led by Santé Ventures to Expand AI-Enabled Nursing Care

October 14, 2025

IMFINZI Regimen Reduces Risk of Disease Recurrence or Death by 32% in High-Risk Non-Muscle-Invasive Bladder Cancer in Phase III POTOMAC Trial

October 17, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Biotech

Boston Scientific to Acquire Nalu Medical in $600 Million Deal to Expand Chronic Pain Solutions

Pimicotinib Shows Deep and Durable Tumor Responses, Sustained Pain Relief, and Functional Improvement in TGCT Patients

Adicet Bio Doses First Patient in Phase 1 Trial of ADI-001 for Treatment-Refractory Rheumatoid Arthritis

Newleos Therapeutics CEO David Donabedian Named One of Goldman Sachs’ Most Exceptional Entrepreneurs of 2025

Landmark Bio and Mass General Brigham Partner to Advance Early-Stage Cell and Gene Therapies

Most Read

Boston Scientific to Acquire Nalu Medical in $600 Million Deal to Expand Chronic Pain Solutions

Savara Announces Chief Medical Officer Transition

IMFINZI Regimen Reduces Risk of Disease Recurrence or Death by 32% in High-Risk Non-Muscle-Invasive Bladder Cancer in Phase III POTOMAC Trial

Pimicotinib Shows Deep and Durable Tumor Responses, Sustained Pain Relief, and Functional Improvement in TGCT Patients

EDITOR PICKS

Boston Scientific to Acquire Nalu Medical in $600 Million Deal to Expand Chronic Pain Solutions

Parabilis Medicines Unveils Groundbreaking Clinical Data Showing First-Ever Drugging of Key Cancer Driver with FOG-001

Zelis Study Finds Employers and Consumers See AI, Price Transparency, and Digital Tools as Keys to Better Healthcare

THIS WEEK'S STORIES

CMS Grants HCPCS Code and NTAP Classification for Pleural Dynamics’ ACES Automatic Continuous Effusion Shunt

OutcomesAI Raises $10 Million Seed Round Led by Santé Ventures to Expand AI-Enabled Nursing Care

IMFINZI Regimen Reduces Risk of Disease Recurrence or Death by 32% in High-Risk Non-Muscle-Invasive Bladder Cancer in Phase III POTOMAC Trial

POPULAR CATEGORY

ABOUT US

FOLLOW US